M&A Deal Summary

Innophos Acquires NutraGenesis

On November 6, 2017, Innophos acquired consumer products company NutraGenesis for 28M USD

Acquisition Highlights
  • This is Innophos’ 2nd transaction in the Consumer Products sector.
  • This is Innophos’ 3rd largest (disclosed) transaction.
  • This is Innophos’ 5th transaction in the United States.
  • This is Innophos’ 1st transaction in Vermont.

M&A Deal Summary

Date 2017-11-06
Target NutraGenesis
Sector Consumer Products
Buyer(s) Innophos
Deal Type Add-on Acquisition
Deal Value 28M USD
Advisor(s) Alantra Partners, S.A. - Investment Bank (Financial)
Downs Rachlin Martin (Legal)

Target

NutraGenesis

Brattleboro, Vermont, United States
NutraGenesis LLC is a manufacturer of proprietary, branded and science-backed nutraceutical ingredients. NutraGenesis LLC was founded in 2003 and is based in Brattleboro, Vermont.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Innophos

Cranbury, New Jersey, United States

Category Company
Founded 2004
Sector Food
Employees1,485
Revenue 802M USD (2018)
DESCRIPTION

Innophos is an international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. Innophos was founded in 2004 and is based in Cranbury, New Jersey.


DEAL STATS #
Overall 5 of 5
Sector (Consumer Products) 2 of 2
Type (Add-on Acquisition) 5 of 5
State (Vermont) 1 of 1
Country (United States) 5 of 5
Year (2017) 2 of 2
Size (of disclosed) 3 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-01 Novel Ingredients

East Hanover, New Jersey, United States

Novel Ingredients is a New Jersey-based provider of dietary supplement ingredient solutions. For over 15 years, Novel Ingredients has established a standard of excellence in the distribution of premium botanical ingredients.

Buy $125M